, Tracking Stock Market Picks
Enter Symbol:
Dyax Corp. (DYAX) [hlAlert]

up 458.17 %

Dyax Corp. (DYAX) rated Buy with price target $5 by UBS

Posted on: Thursday,  Oct 28, 2010  12:25 PM ET by UBS

UBS rated Buy Dyax Corp. (NASDAQ: DYAX) on 10/28/2010. Previously UBS rated Buy Dyax Corp. (NASDAQ: DYAX) on 07/30/2008., when
the stock price was $4.28. Since then, Dyax Corp. has gained 458.18% as of 11/05/2015's recent price of $23.89.
If you would have followed the previous UBS's recommendation on DYAX, you would have gained 458.17% of your investment in 2654 days.

Dyax Corp is a biopharmaceutical company that has developed and patented a method that is used to identify a broad range of compounds with potential for the treatment and diagnosis of diseases. The company is also using this method to identify compounds that could be used in purifying andmanufacturing biopharmaceuticals and other chemicals. The company's phage display technology to rapidly and cost-effectively determine the potential medical uses of newly discovered proteins and genes and subsequently discover biopharmaceutical product candidates.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/28/2010 12:25 PM Buy
2.39 5.00
as of 12/31/2010
1 Week down  -9.13 %
1 Month down  -11.94 %
3 Months down  -16.03 %
1 YTD down  -41.29 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/26/2009 1:25 PM Buy
1.90 5.00
7/30/2008 10:25 AM Buy
4.28 7.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy